

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ovulation from ovarian follicle (GO:0001542) | 8.21644416 |
| 2 | epithelial cell maturation (GO:0002070) | 7.42523415 |
| 3 | iron ion import (GO:0097286) | 6.57708247 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.22080195 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 6.22080195 |
| 6 | desmosome organization (GO:0002934) | 6.11645959 |
| 7 | regulation of water loss via skin (GO:0033561) | 6.11431798 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.82798349 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 5.82798349 |
| 10 | purine nucleotide transport (GO:0015865) | 5.79920174 |
| 11 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 5.68855073 |
| 12 | NLS-bearing protein import into nucleus (GO:0006607) | 5.58209760 |
| 13 | biotin metabolic process (GO:0006768) | 5.46631294 |
| 14 | cardiac right ventricle morphogenesis (GO:0003215) | 5.46094014 |
| 15 | aromatic amino acid family catabolic process (GO:0009074) | 5.41560464 |
| 16 | intestinal epithelial cell development (GO:0060576) | 5.13562229 |
| 17 | glucocorticoid metabolic process (GO:0008211) | 5.05950388 |
| 18 | establishment of skin barrier (GO:0061436) | 5.02614524 |
| 19 | diol metabolic process (GO:0034311) | 4.98327990 |
| 20 | COPI coating of Golgi vesicle (GO:0048205) | 4.94147485 |
| 21 | Golgi transport vesicle coating (GO:0048200) | 4.94147485 |
| 22 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.85240309 |
| 23 | regulation of hippo signaling (GO:0035330) | 4.83185923 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 4.71417333 |
| 25 | tryptophan metabolic process (GO:0006568) | 4.71250421 |
| 26 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.71052610 |
| 27 | tryptophan catabolic process (GO:0006569) | 4.66776677 |
| 28 | indole-containing compound catabolic process (GO:0042436) | 4.66776677 |
| 29 | indolalkylamine catabolic process (GO:0046218) | 4.66776677 |
| 30 | kynurenine metabolic process (GO:0070189) | 4.45095007 |
| 31 | sulfur amino acid catabolic process (GO:0000098) | 4.40578009 |
| 32 | ear development (GO:0043583) | 4.39287546 |
| 33 | amyloid precursor protein catabolic process (GO:0042987) | 4.38024045 |
| 34 | protein carboxylation (GO:0018214) | 4.27572317 |
| 35 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.27572317 |
| 36 | reverse cholesterol transport (GO:0043691) | 4.26402625 |
| 37 | alpha-linolenic acid metabolic process (GO:0036109) | 4.18769737 |
| 38 | tyrosine metabolic process (GO:0006570) | 4.18632454 |
| 39 | ovulation (GO:0030728) | 4.18533494 |
| 40 | sphingoid metabolic process (GO:0046519) | 4.16919749 |
| 41 | tight junction assembly (GO:0070830) | 4.16698412 |
| 42 | cysteine metabolic process (GO:0006534) | 4.12809690 |
| 43 | COPII vesicle coating (GO:0048208) | 4.12786652 |
| 44 | intestinal cholesterol absorption (GO:0030299) | 4.09555315 |
| 45 | multicellular organismal water homeostasis (GO:0050891) | 4.07244293 |
| 46 | bile acid biosynthetic process (GO:0006699) | 4.06195660 |
| 47 | aromatic amino acid family metabolic process (GO:0009072) | 4.04187434 |
| 48 | endocrine pancreas development (GO:0031018) | 4.02865612 |
| 49 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 4.02183322 |
| 50 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 4.00521578 |
| 51 | urea cycle (GO:0000050) | 4.00515840 |
| 52 | urea metabolic process (GO:0019627) | 4.00515840 |
| 53 | growth hormone receptor signaling pathway (GO:0060396) | 3.99322671 |
| 54 | glyoxylate metabolic process (GO:0046487) | 3.97182369 |
| 55 | bile acid metabolic process (GO:0008206) | 3.96037068 |
| 56 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.89031740 |
| 57 | triglyceride homeostasis (GO:0070328) | 3.84524936 |
| 58 | acylglycerol homeostasis (GO:0055090) | 3.84524936 |
| 59 | amyloid precursor protein metabolic process (GO:0042982) | 3.83412258 |
| 60 | indolalkylamine metabolic process (GO:0006586) | 3.82298455 |
| 61 | homocysteine metabolic process (GO:0050667) | 3.80628416 |
| 62 | macromolecular complex remodeling (GO:0034367) | 3.80335877 |
| 63 | plasma lipoprotein particle remodeling (GO:0034369) | 3.80335877 |
| 64 | protein-lipid complex remodeling (GO:0034368) | 3.80335877 |
| 65 | regulation of fibrinolysis (GO:0051917) | 3.79112016 |
| 66 | phospholipid efflux (GO:0033700) | 3.78898700 |
| 67 | bile acid and bile salt transport (GO:0015721) | 3.76795590 |
| 68 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043) | 3.75057878 |
| 69 | regulation of cholesterol esterification (GO:0010872) | 3.72298270 |
| 70 | negative regulation of fibrinolysis (GO:0051918) | 3.69181522 |
| 71 | cellular response to growth hormone stimulus (GO:0071378) | 3.68250847 |
| 72 | nitrogen cycle metabolic process (GO:0071941) | 3.64597249 |
| 73 | ectoderm development (GO:0007398) | 3.64113240 |
| 74 | cholesterol efflux (GO:0033344) | 3.62882839 |
| 75 | negative regulation of sterol transport (GO:0032372) | 3.61677367 |
| 76 | negative regulation of cholesterol transport (GO:0032375) | 3.61677367 |
| 77 | vesicle coating (GO:0006901) | 3.61618020 |
| 78 | complement activation, alternative pathway (GO:0006957) | 3.61211370 |
| 79 | lysine metabolic process (GO:0006553) | 3.58738904 |
| 80 | lysine catabolic process (GO:0006554) | 3.58738904 |
| 81 | serine family amino acid catabolic process (GO:0009071) | 3.58110984 |
| 82 | valine metabolic process (GO:0006573) | 3.57224917 |
| 83 | coenzyme catabolic process (GO:0009109) | 3.55268540 |
| 84 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.55206295 |
| 85 | drug transmembrane transport (GO:0006855) | 3.53776775 |
| 86 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.53622186 |
| 87 | regulation of histone H3-K27 methylation (GO:0061085) | 3.53568554 |
| 88 | phosphate ion homeostasis (GO:0055062) | 3.52206059 |
| 89 | trivalent inorganic anion homeostasis (GO:0072506) | 3.52206059 |
| 90 | alpha-amino acid catabolic process (GO:1901606) | 3.50832778 |
| 91 | benzene-containing compound metabolic process (GO:0042537) | 3.47705380 |
| 92 | oocyte development (GO:0048599) | 3.47027779 |
| 93 | regulation of triglyceride catabolic process (GO:0010896) | 3.46600595 |
| 94 | cellular ketone body metabolic process (GO:0046950) | 3.46296716 |
| 95 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.45926146 |
| 96 | hepatocyte apoptotic process (GO:0097284) | 3.45690490 |
| 97 | regulation of protein activation cascade (GO:2000257) | 3.44855503 |
| 98 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.43941381 |
| 99 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.43675054 |
| 100 | amino-acid betaine transport (GO:0015838) | 3.43511585 |
| 101 | carnitine transport (GO:0015879) | 3.43511585 |
| 102 | intestinal absorption (GO:0050892) | 3.43448937 |
| 103 | maternal placenta development (GO:0001893) | 3.43311086 |
| 104 | cellular modified amino acid catabolic process (GO:0042219) | 3.43005958 |
| 105 | peptide hormone processing (GO:0016486) | 3.42970715 |
| 106 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.41755415 |
| 107 | regulation of cholesterol homeostasis (GO:2000188) | 3.41065100 |
| 108 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 3.39682540 |
| 109 | plasma lipoprotein particle clearance (GO:0034381) | 3.38912178 |
| 110 | water homeostasis (GO:0030104) | 3.37756983 |
| 111 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.37243677 |
| 112 | negative regulation of microtubule polymerization (GO:0031115) | 3.36845669 |
| 113 | drug catabolic process (GO:0042737) | 3.33672267 |
| 114 | cellular amino acid catabolic process (GO:0009063) | 3.33473250 |
| 115 | nucleotide transport (GO:0006862) | 3.33286859 |
| 116 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.30429598 |
| 117 | epithelial cell-cell adhesion (GO:0090136) | 3.29333685 |
| 118 | negative regulation of lipase activity (GO:0060192) | 3.28630027 |
| 119 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.27179854 |
| 120 | short-chain fatty acid metabolic process (GO:0046459) | 3.26751483 |
| 121 | amino-acid betaine metabolic process (GO:0006577) | 3.24885852 |
| 122 | lipoprotein metabolic process (GO:0042157) | 3.24143727 |
| 123 | macroautophagy (GO:0016236) | 3.20301242 |
| 124 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.18461073 |
| 125 | plasma lipoprotein particle assembly (GO:0034377) | 3.18063969 |
| 126 | glutamate metabolic process (GO:0006536) | 3.16845165 |
| 127 | regulation of complement activation (GO:0030449) | 3.16489851 |
| 128 | lung lobe morphogenesis (GO:0060463) | 3.16396859 |
| 129 | regulation of bile acid biosynthetic process (GO:0070857) | 3.16246420 |
| 130 | phospholipid homeostasis (GO:0055091) | 3.12189187 |
| 131 | positive regulation of steroid metabolic process (GO:0045940) | 3.10955182 |
| 132 | ER overload response (GO:0006983) | 3.10318089 |
| 133 | proline biosynthetic process (GO:0006561) | 3.10190522 |
| 134 | cellular response to interferon-alpha (GO:0035457) | 3.09926438 |
| 135 | sphingosine metabolic process (GO:0006670) | 3.09789363 |
| 136 | 4-hydroxyproline metabolic process (GO:0019471) | 3.09558745 |
| 137 | cholesterol homeostasis (GO:0042632) | 3.08779647 |
| 138 | drug metabolic process (GO:0017144) | 3.08139496 |
| 139 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.07319092 |
| 140 | sterol homeostasis (GO:0055092) | 3.07025171 |
| 141 | heparin metabolic process (GO:0030202) | 3.05374241 |
| 142 | heparin biosynthetic process (GO:0030210) | 3.05374241 |
| 143 | cellular biogenic amine catabolic process (GO:0042402) | 3.04748323 |
| 144 | amine catabolic process (GO:0009310) | 3.04748323 |
| 145 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 3.04664524 |
| 146 | cellular glucuronidation (GO:0052695) | 3.04085048 |
| 147 | positive regulation of glycolytic process (GO:0045821) | 3.04044531 |
| 148 | * mammary gland epithelial cell differentiation (GO:0060644) | 3.00680744 |
| 149 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.98894867 |
| 150 | plasma lipoprotein particle organization (GO:0071827) | 2.98328082 |
| 151 | hormone catabolic process (GO:0042447) | 2.97594062 |
| 152 | phosphatidylinositol 3-kinase signaling (GO:0014065) | 2.96961942 |
| 153 | carboxylic acid catabolic process (GO:0046395) | 2.96913454 |
| 154 | organic acid catabolic process (GO:0016054) | 2.96913454 |
| 155 | uterus development (GO:0060065) | 2.96343934 |
| 156 | face development (GO:0060324) | 2.96297167 |
| 157 | ketone body metabolic process (GO:1902224) | 2.95335671 |
| 158 | cardiac ventricle morphogenesis (GO:0003208) | 2.94517335 |
| 159 | type B pancreatic cell proliferation (GO:0044342) | 2.94238883 |
| 160 | 2-oxoglutarate metabolic process (GO:0006103) | 2.93992372 |
| 161 | fatty acid oxidation (GO:0019395) | 2.93632192 |
| 162 | protein retention in ER lumen (GO:0006621) | 2.93414512 |
| 163 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.93161171 |
| 164 | flavonoid metabolic process (GO:0009812) | 2.92924451 |
| 165 | imidazole-containing compound metabolic process (GO:0052803) | 2.92069325 |
| 166 | regulation of establishment of cell polarity (GO:2000114) | 2.90555969 |
| 167 | glandular epithelial cell differentiation (GO:0002067) | 2.88842353 |
| 168 | lipid oxidation (GO:0034440) | 2.86540625 |
| 169 | endocardial cushion development (GO:0003197) | 2.85765747 |
| 170 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.83693706 |
| 171 | endocrine hormone secretion (GO:0060986) | 2.83270938 |
| 172 | interferon-gamma secretion (GO:0072643) | 2.83144989 |
| 173 | regulation of fever generation (GO:0031620) | 2.83092316 |
| 174 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.82649696 |
| 175 | regulation of protein localization to cell surface (GO:2000008) | 2.82482889 |
| 176 | cell differentiation involved in embryonic placenta development (GO:0060706) | 2.82301968 |
| 177 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.81903966 |
| 178 | RNA-dependent DNA replication (GO:0006278) | 2.80519199 |
| 179 | cell-cell junction assembly (GO:0007043) | 2.76805825 |
| 180 | carnitine shuttle (GO:0006853) | 2.75730079 |
| 181 | very long-chain fatty acid metabolic process (GO:0000038) | 2.75339234 |
| 182 | cellular response to antibiotic (GO:0071236) | 2.73900684 |
| 183 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.73883576 |
| 184 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.73292110 |
| 185 | protein complex localization (GO:0031503) | 2.72232199 |
| 186 | positive regulation of heat generation (GO:0031652) | 2.71448604 |
| 187 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.69748409 |
| 188 | dicarboxylic acid catabolic process (GO:0043649) | 2.69344428 |
| 189 | regulation of centriole replication (GO:0046599) | 2.68813965 |
| 190 | sphingomyelin metabolic process (GO:0006684) | 2.65507028 |
| 191 | establishment of apical/basal cell polarity (GO:0035089) | 2.64631196 |
| 192 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.64362605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.18590918 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.31217089 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.26661404 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.21766896 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.73525150 |
| 6 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 4.70489200 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.27005219 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.09929093 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.57428388 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.49103849 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.09627294 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 3.05796636 |
| 13 | ELF5_23300383_ChIP-Seq_T47D_Human | 2.99158250 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.82757327 |
| 15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.67436677 |
| 16 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.54245140 |
| 17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.52403944 |
| 18 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 2.49991683 |
| 19 | KDM5A_27292631_Chip-Seq_BREAST_Human | 2.45422749 |
| 20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.30020021 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.93310105 |
| 22 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.85742748 |
| 23 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.77809431 |
| 24 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.75241848 |
| 25 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.74839632 |
| 26 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.71963678 |
| 27 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.71285191 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.66696081 |
| 29 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60868491 |
| 30 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.60812640 |
| 31 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.57124324 |
| 32 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.55942297 |
| 33 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.54712800 |
| 34 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.54470210 |
| 35 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.50111005 |
| 36 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.48229164 |
| 37 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.47419463 |
| 38 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.43807157 |
| 39 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43790736 |
| 40 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.41998710 |
| 41 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.37064441 |
| 42 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.37062683 |
| 43 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.35351119 |
| 44 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.34348208 |
| 45 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.34243515 |
| 46 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.31433634 |
| 47 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.30955516 |
| 48 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.28605493 |
| 49 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.27896227 |
| 50 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27432702 |
| 51 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.26748294 |
| 52 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.26577916 |
| 53 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24690026 |
| 54 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.23422897 |
| 55 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.22794905 |
| 56 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.22674781 |
| 57 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.21724252 |
| 58 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.20354233 |
| 59 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.19333893 |
| 60 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.17843097 |
| 61 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.17656073 |
| 62 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.16265445 |
| 63 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.15527731 |
| 64 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.11876880 |
| 65 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.11876880 |
| 66 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11735624 |
| 67 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.11475769 |
| 68 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.11243908 |
| 69 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.11039025 |
| 70 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10102782 |
| 71 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10102782 |
| 72 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10090058 |
| 73 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.09073069 |
| 74 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06085769 |
| 75 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05778757 |
| 76 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.05394746 |
| 77 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.02966279 |
| 78 | ATF3_27146783_Chip-Seq_COLON_Human | 1.01647356 |
| 79 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01360928 |
| 80 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.99292779 |
| 81 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.96953122 |
| 82 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.95717328 |
| 83 | * HOXB7_26014856_ChIP-Seq_BT474_Human | 0.94472402 |
| 84 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92686975 |
| 85 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.92111144 |
| 86 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.90541586 |
| 87 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90404802 |
| 88 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.89095406 |
| 89 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.88248304 |
| 90 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.87935779 |
| 91 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.85991910 |
| 92 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.85456579 |
| 93 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.83528431 |
| 94 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.81392489 |
| 95 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.80866849 |
| 96 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.80832837 |
| 97 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80747731 |
| 98 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.80695539 |
| 99 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.80549244 |
| 100 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.80398288 |
| 101 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.79953294 |
| 102 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.79103883 |
| 103 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.78650576 |
| 104 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.78615732 |
| 105 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.78254712 |
| 106 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.77908366 |
| 107 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.77531448 |
| 108 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.77353286 |
| 109 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.76846989 |
| 110 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.76381365 |
| 111 | AR_20517297_ChIP-Seq_VCAP_Human | 0.76284241 |
| 112 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.75934623 |
| 113 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.75767874 |
| 114 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.75712510 |
| 115 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.75478741 |
| 116 | STAT3_23295773_ChIP-Seq_U87_Human | 0.75141208 |
| 117 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.74950051 |
| 118 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.74615712 |
| 119 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.73685688 |
| 120 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.73531766 |
| 121 | RXR_22108803_ChIP-Seq_LS180_Human | 0.72988214 |
| 122 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.72695072 |
| 123 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.72433225 |
| 124 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.72345912 |
| 125 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.72117451 |
| 126 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.71229001 |
| 127 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.71000464 |
| 128 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.70903674 |
| 129 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.70590540 |
| 130 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.70528623 |
| 131 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.70099386 |
| 132 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.69488344 |
| 133 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.69233046 |
| 134 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.68593963 |
| 135 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.68156975 |
| 136 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.68110876 |
| 137 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.68088996 |
| 138 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.67455864 |
| 139 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.67306157 |
| 140 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.66658657 |
| 141 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.66579055 |
| 142 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.66126900 |
| 143 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.66120985 |
| 144 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.65767164 |
| 145 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.65170067 |
| 146 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.64881278 |
| 147 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.64833248 |
| 148 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.64282963 |
| 149 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.64094964 |
| 150 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.63748256 |
| 151 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.63083924 |
| 152 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62541021 |
| 153 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.62077295 |
| 154 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.61281158 |
| 155 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.60468296 |
| 156 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.60229295 |
| 157 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.59076504 |
| 158 | GATA1_19941826_ChIP-Seq_K562_Human | 0.59022967 |
| 159 | CBP_21632823_ChIP-Seq_H3396_Human | 0.58997300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.79937706 |
| 2 | MP0005360_urolithiasis | 5.46161461 |
| 3 | MP0005365_abnormal_bile_salt | 5.20061781 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.91418736 |
| 5 | MP0003195_calcinosis | 4.05789678 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.87209688 |
| 7 | MP0002796_impaired_skin_barrier | 3.60363717 |
| 8 | MP0003252_abnormal_bile_duct | 3.57681829 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.06734116 |
| 10 | MP0004043_abnormal_pH_regulation | 2.68100639 |
| 11 | MP0009780_abnormal_chondrocyte_physiolo | 2.62961591 |
| 12 | MP0004233_abnormal_muscle_weight | 2.57305706 |
| 13 | MP0009384_cardiac_valve_regurgitation | 2.54850512 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.53037129 |
| 15 | MP0010678_abnormal_skin_adnexa | 2.50917517 |
| 16 | MP0004264_abnormal_extraembryonic_tissu | 2.23686661 |
| 17 | MP0005332_abnormal_amino_acid | 2.23201599 |
| 18 | * MP0002693_abnormal_pancreas_physiology | 2.22640324 |
| 19 | MP0001873_stomach_inflammation | 2.22315672 |
| 20 | MP0003941_abnormal_skin_development | 2.22285858 |
| 21 | MP0005501_abnormal_skin_physiology | 2.19592539 |
| 22 | MP0003806_abnormal_nucleotide_metabolis | 2.18981105 |
| 23 | * MP0000627_abnormal_mammary_gland | 2.15622585 |
| 24 | MP0003868_abnormal_feces_composition | 2.15557434 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 2.14197888 |
| 26 | * MP0001944_abnormal_pancreas_morphology | 2.12863208 |
| 27 | MP0009840_abnormal_foam_cell | 2.10257658 |
| 28 | MP0002877_abnormal_melanocyte_morpholog | 2.02457914 |
| 29 | MP0002909_abnormal_adrenal_gland | 1.98503155 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.98367204 |
| 31 | MP0010386_abnormal_urinary_bladder | 1.96962926 |
| 32 | MP0005083_abnormal_biliary_tract | 1.96697332 |
| 33 | MP0005220_abnormal_exocrine_pancreas | 1.95613108 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.92314012 |
| 35 | MP0001727_abnormal_embryo_implantation | 1.86170495 |
| 36 | MP0000609_abnormal_liver_physiology | 1.83336890 |
| 37 | MP0000537_abnormal_urethra_morphology | 1.82935527 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.80991419 |
| 39 | * MP0001919_abnormal_reproductive_system | 1.78563320 |
| 40 | MP0002009_preneoplasia | 1.77458844 |
| 41 | MP0009643_abnormal_urine_homeostasis | 1.75432335 |
| 42 | * MP0002078_abnormal_glucose_homeostasis | 1.73531966 |
| 43 | MP0000377_abnormal_hair_follicle | 1.72149686 |
| 44 | MP0000383_abnormal_hair_follicle | 1.67494861 |
| 45 | MP0003283_abnormal_digestive_organ | 1.63738337 |
| 46 | * MP0000427_abnormal_hair_cycle | 1.61729552 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.59653094 |
| 48 | MP0002876_abnormal_thyroid_physiology | 1.55030434 |
| 49 | MP0002837_dystrophic_cardiac_calcinosis | 1.45522957 |
| 50 | MP0000566_synostosis | 1.44557833 |
| 51 | MP0010352_gastrointestinal_tract_polyps | 1.44368862 |
| 52 | MP0001661_extended_life_span | 1.40274175 |
| 53 | MP0004185_abnormal_adipocyte_glucose | 1.39590667 |
| 54 | MP0002282_abnormal_trachea_morphology | 1.39094852 |
| 55 | MP0003183_abnormal_peptide_metabolism | 1.36437656 |
| 56 | MP0001177_atelectasis | 1.32852649 |
| 57 | MP0003693_abnormal_embryo_hatching | 1.32084050 |
| 58 | MP0005319_abnormal_enzyme/_coenzyme | 1.31370960 |
| 59 | * MP0003936_abnormal_reproductive_system | 1.31245177 |
| 60 | MP0000678_abnormal_parathyroid_gland | 1.30731874 |
| 61 | MP0002254_reproductive_system_inflammat | 1.27386076 |
| 62 | * MP0005636_abnormal_mineral_homeostasis | 1.24320192 |
| 63 | MP0001764_abnormal_homeostasis | 1.23705101 |
| 64 | MP0001216_abnormal_epidermal_layer | 1.21224639 |
| 65 | MP0005647_abnormal_sex_gland | 1.20037964 |
| 66 | MP0001756_abnormal_urination | 1.18679994 |
| 67 | * MP0001765_abnormal_ion_homeostasis | 1.18200383 |
| 68 | MP0000013_abnormal_adipose_tissue | 1.18065560 |
| 69 | MP0004381_abnormal_hair_follicle | 1.15000739 |
| 70 | MP0009697_abnormal_copulation | 1.10480202 |
| 71 | * MP0003953_abnormal_hormone_level | 1.10438262 |
| 72 | MP0005670_abnormal_white_adipose | 1.09570854 |
| 73 | MP0002166_altered_tumor_susceptibility | 1.08785599 |
| 74 | MP0005646_abnormal_pituitary_gland | 1.07494185 |
| 75 | MP0000462_abnormal_digestive_system | 1.06679663 |
| 76 | MP0010234_abnormal_vibrissa_follicle | 1.05315169 |
| 77 | MP0002928_abnormal_bile_duct | 1.04784059 |
| 78 | MP0000639_abnormal_adrenal_gland | 1.02388740 |
| 79 | MP0000538_abnormal_urinary_bladder | 0.99706823 |
| 80 | MP0002168_other_aberrant_phenotype | 0.98525815 |
| 81 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.98095396 |
| 82 | * MP0009642_abnormal_blood_homeostasis | 0.93963662 |
| 83 | * MP0005535_abnormal_body_temperature | 0.93379345 |
| 84 | MP0005310_abnormal_salivary_gland | 0.92867138 |
| 85 | * MP0005379_endocrine/exocrine_gland_phen | 0.92830761 |
| 86 | * MP0005389_reproductive_system_phenotype | 0.92606873 |
| 87 | MP0005408_hypopigmentation | 0.92205854 |
| 88 | * MP0002896_abnormal_bone_mineralization | 0.91488528 |
| 89 | MP0005409_darkened_coat_color | 0.90974815 |
| 90 | MP0000613_abnormal_salivary_gland | 0.89062727 |
| 91 | MP0005187_abnormal_penis_morphology | 0.88748026 |
| 92 | MP0001664_abnormal_digestion | 0.86603873 |
| 93 | MP0001348_abnormal_lacrimal_gland | 0.86260762 |
| 94 | MP0002160_abnormal_reproductive_system | 0.86142491 |
| 95 | * MP0005334_abnormal_fat_pad | 0.84943033 |
| 96 | MP0004883_abnormal_blood_vessel | 0.84192712 |
| 97 | MP0000762_abnormal_tongue_morphology | 0.84085261 |
| 98 | MP0003566_abnormal_cell_adhesion | 0.83401711 |
| 99 | MP0005448_abnormal_energy_balance | 0.81996303 |
| 100 | MP0000598_abnormal_liver_morphology | 0.81589569 |
| 101 | MP0004147_increased_porphyrin_level | 0.78481369 |
| 102 | MP0005058_abnormal_lysosome_morphology | 0.77349119 |
| 103 | MP0010771_integument_phenotype | 0.75909405 |
| 104 | MP0002098_abnormal_vibrissa_morphology | 0.74510588 |
| 105 | MP0000230_abnormal_systemic_arterial | 0.73866994 |
| 106 | MP0003453_abnormal_keratinocyte_physiol | 0.73851105 |
| 107 | MP0000647_abnormal_sebaceous_gland | 0.73780842 |
| 108 | MP0009931_abnormal_skin_appearance | 0.73253399 |
| 109 | MP0002971_abnormal_brown_adipose | 0.73116394 |
| 110 | MP0003705_abnormal_hypodermis_morpholog | 0.71911984 |
| 111 | MP0003315_abnormal_perineum_morphology | 0.71866581 |
| 112 | MP0008004_abnormal_stomach_pH | 0.70498796 |
| 113 | MP0000003_abnormal_adipose_tissue | 0.70427516 |
| 114 | MP0005076_abnormal_cell_differentiation | 0.70000898 |
| 115 | MP0005666_abnormal_adipose_tissue | 0.69654410 |
| 116 | MP0003045_fibrosis | 0.68940248 |
| 117 | MP0000579_abnormal_nail_morphology | 0.68784209 |
| 118 | MP0003186_abnormal_redox_activity | 0.67959362 |
| 119 | MP0001243_abnormal_dermal_layer | 0.65390750 |
| 120 | MP0009763_increased_sensitivity_to | 0.65291206 |
| 121 | MP0005075_abnormal_melanosome_morpholog | 0.65261223 |
| 122 | * MP0000367_abnormal_coat/_hair | 0.64577707 |
| 123 | MP0005451_abnormal_body_composition | 0.63609894 |
| 124 | MP0009764_decreased_sensitivity_to | 0.63363503 |
| 125 | MP0005395_other_phenotype | 0.63334148 |
| 126 | MP0002088_abnormal_embryonic_growth/wei | 0.60241134 |
| 127 | MP0008961_abnormal_basal_metabolism | 0.59828478 |
| 128 | MP0005375_adipose_tissue_phenotype | 0.58042568 |
| 129 | MP0009765_abnormal_xenobiotic_induced | 0.58030729 |
| 130 | MP0000767_abnormal_smooth_muscle | 0.55985950 |
| 131 | MP0000470_abnormal_stomach_morphology | 0.55809928 |
| 132 | MP0002006_tumorigenesis | 0.55743827 |
| 133 | MP0002060_abnormal_skin_morphology | 0.53289790 |
| 134 | MP0003172_abnormal_lysosome_physiology | 0.53071382 |
| 135 | MP0003984_embryonic_growth_retardation | 0.53000371 |
| 136 | MP0008469_abnormal_protein_level | 0.52637199 |
| 137 | MP0002136_abnormal_kidney_physiology | 0.52087901 |
| 138 | MP0003959_abnormal_lean_body | 0.51925451 |
| 139 | * MP0001346_abnormal_lacrimal_gland | 0.51655481 |
| 140 | MP0010030_abnormal_orbit_morphology | 0.51394915 |
| 141 | MP0000604_amyloidosis | 0.51066201 |
| 142 | MP0004782_abnormal_surfactant_physiolog | 0.50635296 |
| 143 | MP0003638_abnormal_response/metabolism_ | 0.50253991 |
| 144 | MP0005376_homeostasis/metabolism_phenot | 0.49390833 |
| 145 | MP0003011_delayed_dark_adaptation | 0.49158590 |
| 146 | MP0000467_abnormal_esophagus_morphology | 0.49105147 |
| 147 | MP0005380_embryogenesis_phenotype | 0.48462581 |
| 148 | MP0001672_abnormal_embryogenesis/_devel | 0.48462581 |
| 149 | * MP0001881_abnormal_mammary_gland | 0.48120089 |
| 150 | MP0004272_abnormal_basement_membrane | 0.48041667 |
| 151 | MP0010368_abnormal_lymphatic_system | 0.43967774 |
| 152 | MP0009672_abnormal_birth_weight | 0.43905757 |
| 153 | MP0001879_abnormal_lymphatic_vessel | 0.43764729 |
| 154 | * MP0002086_abnormal_extraembryonic_tissu | 0.43337320 |
| 155 | MP0009703_decreased_birth_body | 0.42939837 |
| 156 | MP0004130_abnormal_muscle_cell | 0.42887789 |
| 157 | MP0008057_abnormal_DNA_replication | 0.42188375 |
| 158 | MP0000490_abnormal_crypts_of | 0.42186145 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Concave nail (HP:0001598) | 8.46029423 |
| 2 | Sparse lateral eyebrow (HP:0005338) | 8.01363270 |
| 3 | Abnormality of nail color (HP:0100643) | 6.37983093 |
| 4 | Flat capital femoral epiphysis (HP:0003370) | 6.37629387 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.31196068 |
| 6 | Hypoglycemic coma (HP:0001325) | 6.08263567 |
| 7 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 6.01248445 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 5.85306986 |
| 9 | Hypoglycemic seizures (HP:0002173) | 5.70642193 |
| 10 | Hyperinsulinemic hypoglycemia (HP:0000825) | 5.59122754 |
| 11 | Right ventricular cardiomyopathy (HP:0011663) | 5.32592096 |
| 12 | Prolonged partial thromboplastin time (HP:0003645) | 5.30175870 |
| 13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.21894739 |
| 14 | Deep venous thrombosis (HP:0002625) | 4.95513420 |
| 15 | Xanthomatosis (HP:0000991) | 4.93159892 |
| 16 | Curly hair (HP:0002212) | 4.86461105 |
| 17 | Symptomatic seizures (HP:0011145) | 4.83128023 |
| 18 | Deep philtrum (HP:0002002) | 4.72752643 |
| 19 | Ketoacidosis (HP:0001993) | 4.64299066 |
| 20 | Conjugated hyperbilirubinemia (HP:0002908) | 4.58871023 |
| 21 | Pili torti (HP:0003777) | 4.56607377 |
| 22 | Abnormality of the intrinsic pathway (HP:0010989) | 4.55661041 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 4.46742087 |
| 24 | Flat acetabular roof (HP:0003180) | 4.45127314 |
| 25 | Hyperglycemia (HP:0003074) | 4.43402698 |
| 26 | Ketosis (HP:0001946) | 4.32298160 |
| 27 | Hypobetalipoproteinemia (HP:0003563) | 4.31693716 |
| 28 | Exostoses (HP:0100777) | 4.31280899 |
| 29 | Breast carcinoma (HP:0003002) | 4.24813097 |
| 30 | Hyperlipoproteinemia (HP:0010980) | 4.24061396 |
| 31 | Infantile muscular hypotonia (HP:0008947) | 4.01624165 |
| 32 | Abnormality of the distal phalanges of the toes (HP:0010182) | 3.97806985 |
| 33 | Insidious onset (HP:0003587) | 3.78871793 |
| 34 | Termporal pattern (HP:0011008) | 3.78871793 |
| 35 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.78849188 |
| 36 | Generalized aminoaciduria (HP:0002909) | 3.65441655 |
| 37 | Fat malabsorption (HP:0002630) | 3.52630790 |
| 38 | Joint hemorrhage (HP:0005261) | 3.51156714 |
| 39 | Epidermoid cyst (HP:0200040) | 3.49021534 |
| 40 | Hypolipoproteinemia (HP:0010981) | 3.41559430 |
| 41 | Abnormal tarsal ossification (HP:0008369) | 3.41401394 |
| 42 | Late onset (HP:0003584) | 3.30158349 |
| 43 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.27729452 |
| 44 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.27152276 |
| 45 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.26345336 |
| 46 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.26345336 |
| 47 | Thin bony cortex (HP:0002753) | 3.24765909 |
| 48 | Septate vagina (HP:0001153) | 3.18390912 |
| 49 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 3.15201191 |
| 50 | Hypoalphalipoproteinemia (HP:0003233) | 3.14142836 |
| 51 | Hyperglycinuria (HP:0003108) | 3.12711490 |
| 52 | Hyperglycinemia (HP:0002154) | 3.11567848 |
| 53 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.10814209 |
| 54 | Complement deficiency (HP:0004431) | 3.10567599 |
| 55 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.09770806 |
| 56 | Abnormality of purine metabolism (HP:0004352) | 3.07985922 |
| 57 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 3.07673991 |
| 58 | Abnormal hair laboratory examination (HP:0003328) | 3.05533801 |
| 59 | Hyperammonemia (HP:0001987) | 3.00477483 |
| 60 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.85284244 |
| 61 | Distal lower limb muscle weakness (HP:0009053) | 2.85175299 |
| 62 | Abnormality of glycine metabolism (HP:0010895) | 2.75837239 |
| 63 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.75837239 |
| 64 | Skin nodule (HP:0200036) | 2.74269369 |
| 65 | Germ cell neoplasia (HP:0100728) | 2.73707067 |
| 66 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.70853978 |
| 67 | Mucopolysacchariduria (HP:0008155) | 2.70853978 |
| 68 | Hyperbilirubinemia (HP:0002904) | 2.69789503 |
| 69 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.68871799 |
| 70 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.68686262 |
| 71 | Abnormality of the epiphyses of the hand (HP:0005924) | 2.68037236 |
| 72 | Abnormality of nucleobase metabolism (HP:0010932) | 2.65880346 |
| 73 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.61779333 |
| 74 | Delayed CNS myelination (HP:0002188) | 2.60914972 |
| 75 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.60893568 |
| 76 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.60812483 |
| 77 | Congenital glaucoma (HP:0001087) | 2.60663983 |
| 78 | Hypercholesterolemia (HP:0003124) | 2.59854142 |
| 79 | Abnormal foot bone ossification (HP:0010675) | 2.59320036 |
| 80 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 2.58161809 |
| 81 | Abnormality of methionine metabolism (HP:0010901) | 2.57829158 |
| 82 | Insulin resistance (HP:0000855) | 2.53300880 |
| 83 | Microretrognathia (HP:0000308) | 2.51934947 |
| 84 | Gout (HP:0001997) | 2.51885205 |
| 85 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.51612622 |
| 86 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.51612622 |
| 87 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.51612622 |
| 88 | Partial duplication of thumb phalanx (HP:0009944) | 2.51240628 |
| 89 | Increased number of teeth (HP:0011069) | 2.49532117 |
| 90 | Flattened epiphyses (HP:0003071) | 2.42441834 |
| 91 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.40660355 |
| 92 | Osteoarthritis (HP:0002758) | 2.40478558 |
| 93 | Smooth philtrum (HP:0000319) | 2.37867084 |
| 94 | Broad metatarsal (HP:0001783) | 2.36954376 |
| 95 | Short 1st metacarpal (HP:0010034) | 2.35208842 |
| 96 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.35208842 |
| 97 | Testicular atrophy (HP:0000029) | 2.33425864 |
| 98 | Hypotension (HP:0002615) | 2.32986216 |
| 99 | Bone pain (HP:0002653) | 2.32284096 |
| 100 | Hypoparathyroidism (HP:0000829) | 2.29965883 |
| 101 | Metabolic acidosis (HP:0001942) | 2.29304205 |
| 102 | Vascular calcification (HP:0004934) | 2.26422185 |
| 103 | Irritability (HP:0000737) | 2.25694797 |
| 104 | Abnormality of urine glucose concentration (HP:0011016) | 2.24949965 |
| 105 | Glycosuria (HP:0003076) | 2.24949965 |
| 106 | Short nail (HP:0001799) | 2.23262767 |
| 107 | Severe short stature (HP:0003510) | 2.22596522 |
| 108 | Cardiomegaly (HP:0001640) | 2.21528218 |
| 109 | Short metatarsal (HP:0010743) | 2.21204862 |
| 110 | Interstitial pulmonary disease (HP:0006530) | 2.21188353 |
| 111 | Steatorrhea (HP:0002570) | 2.19398627 |
| 112 | Decreased circulating renin level (HP:0003351) | 2.18994840 |
| 113 | Partial duplication of the phalanx of hand (HP:0009999) | 2.15936715 |
| 114 | Osteomalacia (HP:0002749) | 2.15434049 |
| 115 | Akinesia (HP:0002304) | 2.15192082 |
| 116 | Abnormality of the 1st metacarpal (HP:0010009) | 2.14363138 |
| 117 | Hypokinesia (HP:0002375) | 2.14326371 |
| 118 | Widely patent fontanelles and sutures (HP:0004492) | 2.13655468 |
| 119 | Pancreatitis (HP:0001733) | 2.13023947 |
| 120 | Alkalosis (HP:0001948) | 2.11800359 |
| 121 | Enlarged kidneys (HP:0000105) | 2.11545768 |
| 122 | Hepatocellular carcinoma (HP:0001402) | 2.11028576 |
| 123 | Abnormality of carpal bone ossification (HP:0006257) | 2.08097661 |
| 124 | Abdominal distention (HP:0003270) | 2.07722251 |
| 125 | Dysostosis multiplex (HP:0000943) | 2.06819519 |
| 126 | Missing ribs (HP:0000921) | 2.05456518 |
| 127 | Renal cortical cysts (HP:0000803) | 2.04891183 |
| 128 | Myocardial infarction (HP:0001658) | 2.04606488 |
| 129 | Protuberant abdomen (HP:0001538) | 2.03602516 |
| 130 | Abnormal pancreas size (HP:0012094) | 2.03070941 |
| 131 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.02808249 |
| 132 | Retinal atrophy (HP:0001105) | 2.02119597 |
| 133 | Hyporeflexia of lower limbs (HP:0002600) | 2.01141916 |
| 134 | Elevated alkaline phosphatase (HP:0003155) | 2.00691586 |
| 135 | Abnormality of complement system (HP:0005339) | 2.00609629 |
| 136 | Testicular neoplasm (HP:0010788) | 1.99252561 |
| 137 | Scapular winging (HP:0003691) | 1.98547031 |
| 138 | Cardiovascular calcification (HP:0011915) | 1.97961037 |
| 139 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.97730303 |
| 140 | Dicarboxylic aciduria (HP:0003215) | 1.97730303 |
| 141 | Macroorchidism (HP:0000053) | 1.97378312 |
| 142 | Abnormality of proline metabolism (HP:0010907) | 1.97325680 |
| 143 | Hydroxyprolinuria (HP:0003080) | 1.97325680 |
| 144 | Hypotrichosis (HP:0001006) | 1.97315371 |
| 145 | Advanced eruption of teeth (HP:0006288) | 1.96573155 |
| 146 | Spontaneous abortion (HP:0005268) | 1.94311283 |
| 147 | Sensorimotor neuropathy (HP:0007141) | 1.92827088 |
| 148 | Hypokalemia (HP:0002900) | 1.92008453 |
| 149 | Malnutrition (HP:0004395) | 1.91990562 |
| 150 | Diminished movement (HP:0002374) | 1.91722807 |
| 151 | Acute hepatic failure (HP:0006554) | 1.91318774 |
| 152 | Abnormal hand bone ossification (HP:0010660) | 1.91057293 |
| 153 | Hypophosphatemia (HP:0002148) | 1.90866066 |
| 154 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.90551443 |
| 155 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 1.87891568 |
| 156 | Proximal tubulopathy (HP:0000114) | 1.87177674 |
| 157 | Amelogenesis imperfecta (HP:0000705) | 1.86904149 |
| 158 | Aplasia/Hypoplasia of metatarsal bones (HP:0001964) | 1.86898996 |
| 159 | Back pain (HP:0003418) | 1.86536107 |
| 160 | Large for gestational age (HP:0001520) | 1.85479839 |
| 161 | Brushfield spots (HP:0001088) | 1.84888604 |
| 162 | Abnormality of the gastric mucosa (HP:0004295) | 1.84305385 |
| 163 | Acanthocytosis (HP:0001927) | 1.82650974 |
| 164 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.81669193 |
| 165 | Rickets (HP:0002748) | 1.81000199 |
| 166 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.80827829 |
| 167 | Conjunctival hamartoma (HP:0100780) | 1.80320210 |
| 168 | Limb hypertonia (HP:0002509) | 1.80005736 |
| 169 | Sparse eyelashes (HP:0000653) | 1.76721346 |
| 170 | Ovoid vertebral bodies (HP:0003300) | 1.76382287 |
| 171 | Tongue fasciculations (HP:0001308) | 1.76340555 |
| 172 | Woolly hair (HP:0002224) | 1.75613653 |
| 173 | Narrow palate (HP:0000189) | 1.75198438 |
| 174 | Osteolytic defects of the hand bones (HP:0009699) | 1.73983714 |
| 175 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.73983714 |
| 176 | Papillary thyroid carcinoma (HP:0002895) | 1.73698259 |
| 177 | Parakeratosis (HP:0001036) | 1.72954750 |
| 178 | Tubulointerstitial nephritis (HP:0001970) | 1.70436462 |
| 179 | Abnormality of the femoral head (HP:0003368) | 1.69014744 |
| 180 | Buphthalmos (HP:0000557) | 1.68952814 |
| 181 | Lip pit (HP:0100267) | 1.66968464 |
| 182 | Enlarged penis (HP:0000040) | 1.66334475 |
| 183 | Hamartoma of the eye (HP:0010568) | 1.66220120 |
| 184 | Abnormality of femoral epiphyses (HP:0006499) | 1.65693831 |
| 185 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 1.65693831 |
| 186 | Coxa vara (HP:0002812) | 1.64951758 |
| 187 | Asymmetry of the thorax (HP:0001555) | 1.64335355 |
| 188 | Short phalanx of the thumb (HP:0009660) | 1.63657892 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 6.42341322 |
| 2 | TAOK3 | 4.99556962 |
| 3 | TESK1 | 4.80689835 |
| 4 | FRK | 3.82455920 |
| 5 | EIF2AK1 | 3.73179721 |
| 6 | EPHA2 | 3.72995646 |
| 7 | MAPKAPK3 | 3.27731038 |
| 8 | TSSK6 | 3.24310682 |
| 9 | PKN2 | 3.16127192 |
| 10 | ERN1 | 3.10115631 |
| 11 | SIK1 | 2.98657355 |
| 12 | BCKDK | 2.92080883 |
| 13 | LATS1 | 2.77278895 |
| 14 | AKT3 | 2.68407438 |
| 15 | PASK | 2.55188477 |
| 16 | LIMK1 | 2.50994376 |
| 17 | MAPK15 | 2.35740767 |
| 18 | RPS6KB2 | 2.31906835 |
| 19 | MAP3K2 | 2.26664618 |
| 20 | FGFR4 | 2.07870729 |
| 21 | IRAK3 | 1.98434939 |
| 22 | FLT3 | 1.98337677 |
| 23 | TESK2 | 1.92333030 |
| 24 | HIPK2 | 1.84829471 |
| 25 | EPHA3 | 1.71021580 |
| 26 | LATS2 | 1.65062640 |
| 27 | ICK | 1.56359699 |
| 28 | DMPK | 1.54928162 |
| 29 | PTK6 | 1.52301415 |
| 30 | GRK6 | 1.49938665 |
| 31 | PIK3CG | 1.44743554 |
| 32 | IRAK1 | 1.36449156 |
| 33 | PRKD3 | 1.36162340 |
| 34 | ZAP70 | 1.35609187 |
| 35 | WNK4 | 1.33474714 |
| 36 | WEE1 | 1.32165019 |
| 37 | MST1R | 1.31017129 |
| 38 | FGFR2 | 1.27598550 |
| 39 | CDK7 | 1.27174334 |
| 40 | TAF1 | 1.22680589 |
| 41 | CDK12 | 1.22377611 |
| 42 | MET | 1.22316750 |
| 43 | MUSK | 1.20911605 |
| 44 | EEF2K | 1.19975418 |
| 45 | PDGFRA | 1.18466484 |
| 46 | NUAK1 | 1.16380418 |
| 47 | EIF2AK3 | 1.15949384 |
| 48 | PNCK | 1.10316738 |
| 49 | MAP3K1 | 1.10264734 |
| 50 | STK39 | 1.08977814 |
| 51 | PTK2 | 1.06984198 |
| 52 | FER | 1.01668310 |
| 53 | JAK1 | 0.96658191 |
| 54 | SMG1 | 0.96092296 |
| 55 | MAP3K3 | 0.91303231 |
| 56 | CDC42BPA | 0.91194332 |
| 57 | PAK4 | 0.89784252 |
| 58 | NLK | 0.87618752 |
| 59 | FGFR3 | 0.86980706 |
| 60 | PAK2 | 0.85437293 |
| 61 | NTRK1 | 0.82933262 |
| 62 | SGK2 | 0.81379179 |
| 63 | PRKAA2 | 0.79509866 |
| 64 | STK38L | 0.76126847 |
| 65 | MAP2K1 | 0.75483416 |
| 66 | PRKAA1 | 0.71803071 |
| 67 | ERBB4 | 0.70936179 |
| 68 | IRAK2 | 0.69779438 |
| 69 | ADRBK2 | 0.69237663 |
| 70 | CAMKK2 | 0.66990084 |
| 71 | SGK3 | 0.64932007 |
| 72 | LRRK2 | 0.64676939 |
| 73 | MAP2K4 | 0.64551246 |
| 74 | PIK3CA | 0.64183608 |
| 75 | PRKCH | 0.62745960 |
| 76 | CAMK1D | 0.62740016 |
| 77 | EPHB1 | 0.62679864 |
| 78 | MINK1 | 0.62370019 |
| 79 | RET | 0.60427813 |
| 80 | NEK9 | 0.59863826 |
| 81 | ALK | 0.59822137 |
| 82 | GSK3A | 0.58644945 |
| 83 | CAMK1G | 0.57528877 |
| 84 | TYK2 | 0.57355169 |
| 85 | * JAK2 | 0.56581979 |
| 86 | PBK | 0.55986727 |
| 87 | WNK3 | 0.55793995 |
| 88 | SCYL2 | 0.55574259 |
| 89 | STK3 | 0.54250525 |
| 90 | PAK3 | 0.54061316 |
| 91 | PRKCE | 0.53992362 |
| 92 | AURKB | 0.53615543 |
| 93 | VRK2 | 0.53603686 |
| 94 | BMPR2 | 0.53167021 |
| 95 | SGK494 | 0.52992777 |
| 96 | SGK223 | 0.52992777 |
| 97 | BRSK2 | 0.52959335 |
| 98 | MAP3K12 | 0.52762093 |
| 99 | ILK | 0.52397189 |
| 100 | CSNK1E | 0.52265027 |
| 101 | IGF1R | 0.51791407 |
| 102 | MAP2K6 | 0.51562623 |
| 103 | PRKCZ | 0.50438833 |
| 104 | TTK | 0.50242258 |
| 105 | OXSR1 | 0.50036792 |
| 106 | BRD4 | 0.48753936 |
| 107 | JAK3 | 0.47150945 |
| 108 | PRKACG | 0.46731181 |
| 109 | GRK1 | 0.46587018 |
| 110 | MAPK11 | 0.44032433 |
| 111 | MAP3K14 | 0.43298157 |
| 112 | RIPK1 | 0.42888844 |
| 113 | TRIB3 | 0.42029241 |
| 114 | NTRK3 | 0.39776809 |
| 115 | DYRK1B | 0.39115833 |
| 116 | TAOK1 | 0.39065044 |
| 117 | EIF2AK2 | 0.37758881 |
| 118 | YES1 | 0.36735755 |
| 119 | RPS6KB1 | 0.36659203 |
| 120 | PDPK1 | 0.34514335 |
| 121 | CAMK2B | 0.34482209 |
| 122 | STK38 | 0.34285360 |
| 123 | CHUK | 0.32018842 |
| 124 | MST4 | 0.31380699 |
| 125 | CAMK2G | 0.29204558 |
| 126 | ITK | 0.28826492 |
| 127 | MTOR | 0.28618719 |
| 128 | MAP2K2 | 0.27366652 |
| 129 | PRKD2 | 0.26603862 |
| 130 | CDK6 | 0.26462214 |
| 131 | MAP3K9 | 0.25570822 |
| 132 | NEK2 | 0.25115743 |
| 133 | PDGFRB | 0.24757182 |
| 134 | PRKCA | 0.24535727 |
| 135 | TNK2 | 0.24457495 |
| 136 | MAPKAPK5 | 0.23413449 |
| 137 | PRKCI | 0.23160502 |
| 138 | PRKACA | 0.22341304 |
| 139 | UHMK1 | 0.22125044 |
| 140 | ERBB2 | 0.22000587 |
| 141 | PRKD1 | 0.21557690 |
| 142 | MAPKAPK2 | 0.20963426 |
| 143 | CAMK2D | 0.20819644 |
| 144 | PLK1 | 0.20814595 |
| 145 | CSNK1A1 | 0.20459943 |
| 146 | RPS6KA2 | 0.19063435 |
| 147 | IKBKE | 0.18253081 |
| 148 | CSNK2A2 | 0.18113791 |
| 149 | BCR | 0.17958299 |
| 150 | NEK6 | 0.17884600 |
| 151 | MAPK3 | 0.17810688 |
| 152 | AKT2 | 0.17665465 |
| 153 | SRC | 0.17585651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.84640147 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.28336618 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.18197248 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.04352167 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.91801751 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.82352464 |
| 7 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.81296646 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39724027 |
| 9 | Thyroid cancer_Homo sapiens_hsa05216 | 2.33143788 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.24621852 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.20026520 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.19694002 |
| 13 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.13576827 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.12915513 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.10961712 |
| 16 | Protein export_Homo sapiens_hsa03060 | 2.08952366 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.08143709 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.08124218 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.03772767 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93792026 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.92696549 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.90565768 |
| 23 | Endometrial cancer_Homo sapiens_hsa05213 | 1.88773677 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.80568047 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.80294110 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.73608873 |
| 27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.71030575 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.69097155 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.57497027 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.56682173 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55752420 |
| 32 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.54828589 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.52963216 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.52739370 |
| 35 | ABC transporters_Homo sapiens_hsa02010 | 1.51202998 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.51064071 |
| 37 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.50357765 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.48590115 |
| 39 | Hepatitis C_Homo sapiens_hsa05160 | 1.48205776 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.42513042 |
| 41 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.42385648 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41622670 |
| 43 | Bile secretion_Homo sapiens_hsa04976 | 1.40925269 |
| 44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.39697143 |
| 45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.36686535 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.35281123 |
| 47 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.34119630 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 1.33483498 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.33168472 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.26801434 |
| 51 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.25213000 |
| 52 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.25158450 |
| 53 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.24599979 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.18125044 |
| 55 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.17026977 |
| 56 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.14807799 |
| 57 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.13636599 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13547346 |
| 59 | Endocytosis_Homo sapiens_hsa04144 | 1.11827501 |
| 60 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.06936556 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.05396032 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.04783880 |
| 63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.04460973 |
| 64 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.03142913 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.02178100 |
| 66 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.01928185 |
| 67 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.00881238 |
| 68 | Prostate cancer_Homo sapiens_hsa05215 | 0.99861550 |
| 69 | Tight junction_Homo sapiens_hsa04530 | 0.99353688 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.98367829 |
| 71 | Insulin secretion_Homo sapiens_hsa04911 | 0.96147496 |
| 72 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.93461436 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.92472723 |
| 74 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.92136672 |
| 75 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.90719052 |
| 76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90010161 |
| 77 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89879345 |
| 78 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.88706215 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83207736 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.82940634 |
| 81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82435440 |
| 82 | Bladder cancer_Homo sapiens_hsa05219 | 0.80681414 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.77667113 |
| 84 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.77357412 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.77165823 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.76541962 |
| 87 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76444015 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72429368 |
| 89 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.71072152 |
| 90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.68197578 |
| 91 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.64241787 |
| 92 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63051808 |
| 93 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62848472 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60135093 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.58819391 |
| 96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.58802691 |
| 97 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.58728310 |
| 98 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.58632876 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58345172 |
| 100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57013161 |
| 101 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56543392 |
| 102 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55152814 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.54577408 |
| 104 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.51577467 |
| 105 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50261315 |
| 106 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50259667 |
| 107 | Carbon metabolism_Homo sapiens_hsa01200 | 0.49545000 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.48654221 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.47275414 |
| 110 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.46946986 |
| 111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46756481 |
| 112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44529512 |
| 113 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.42736063 |
| 114 | Axon guidance_Homo sapiens_hsa04360 | 0.41636930 |
| 115 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.41174454 |
| 116 | Hepatitis B_Homo sapiens_hsa05161 | 0.40874022 |
| 117 | Lysosome_Homo sapiens_hsa04142 | 0.40712685 |
| 118 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.40519111 |
| 119 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40487261 |
| 120 | Legionellosis_Homo sapiens_hsa05134 | 0.40463076 |
| 121 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.40413237 |
| 122 | Adherens junction_Homo sapiens_hsa04520 | 0.39949496 |
| 123 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.39197467 |
| 124 | Other glycan degradation_Homo sapiens_hsa00511 | 0.37072593 |
| 125 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36106216 |
| 126 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.35922725 |
| 127 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.34970587 |
| 128 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.34716771 |
| 129 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.33874139 |
| 130 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33780963 |
| 131 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33559000 |
| 132 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.33288883 |
| 133 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.32790217 |
| 134 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32265399 |
| 135 | Prion diseases_Homo sapiens_hsa05020 | 0.32251775 |
| 136 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.31788553 |
| 137 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.28906020 |
| 138 | Colorectal cancer_Homo sapiens_hsa05210 | 0.28879313 |
| 139 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27662804 |
| 140 | Circadian rhythm_Homo sapiens_hsa04710 | 0.27295055 |
| 141 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.27130202 |
| 142 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.26793268 |
| 143 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25199190 |
| 144 | Cocaine addiction_Homo sapiens_hsa05030 | 0.23878301 |
| 145 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.22122519 |
| 146 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.21853853 |
| 147 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.20888882 |
| 148 | Sulfur relay system_Homo sapiens_hsa04122 | 0.18627569 |
| 149 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.17345666 |
| 150 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.15082361 |
| 151 | Mineral absorption_Homo sapiens_hsa04978 | 0.11910251 |
| 152 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.11219668 |
| 153 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.11210227 |
| 154 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.09867508 |
| 155 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.09466001 |

